Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating photothermal therapy using an individually tailored treatment plan proposed by Macula Explorer, delivered by the NavilasAE Laser System, to treat individuals aged 60 to 90 with intermediate Age-related Macular Degeneration iAMD. The study aims to see if this approach can safely improve photoreceptor health and slow disease progression by preserving the Ellipsoid Zone Integrity EZI. Participants will be randomly assigned to receive either the photothermal therapy or a sham treatment in the study eye. The study involves 12 visits monthly for the first three months, then quarterly visits continue for up to two years. The therapy is delivered via a specialized laser system with personalized dosing. During the study, participants will undergo eye exams and assessments to monitor photoreceptor health and disease progression, including evaluating the Ellipsoid Zone Integrity at 12 months as the primary outcome. Secondary outcomes include changes in drusen progression, rates of progression to advanced forms of AMD, and visual acuity loss over 24 months. Participants will be closely monitored throughout the study to assess safety and effectiveness over this period.